PFSA net incomeQ2 2026-$8.76M
PFSA net income was -$8.76M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$2.35M a year earlier. For the full fiscal 2025 it was -$35.82M, compared with -$9.23M in fiscal 2024.
Profusa Inc. (PFSA) financials
For the twelve months ended Jun 30, 2026, Profusa Inc. reported -$42.97M of net income.
- Net income, TTM
- -$42.97M
- Cash
- $719.0K
- Market cap
- $332,985
FY2022FY2024
FY2022FY2025
PFSA revenue and earnings growth
PFSA EPSQ2 2026-$151.80
PFSA diluted EPS was -$151.80 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$107.01.
PFSA free cash flowQ2 2026-$2.71M
PFSA free cash flow was -$2.71M in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$16.26M.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | - | $100.0K | - | $8.94M |
| Research and development | $2.80M | $1.61M | - | - |
| Selling, general and admin | $24.90M | $2.99M | - | - |
| Operating income | -$27.71M | -$4.50M | -$1.51M | -$1.27M |
| Interest expense | $2.52M | $4.42M | - | - |
| Pre-tax income | - | -$8.63M | $1.62M | $7.67M |
| Income tax | - | $80.5K | $456.8K | $499.2K |
| Net income | -$35.82M | -$9.23M | $1.16M | $7.17M |
| EPS, basic | -$107.01 | -$357.14 | $0.12 | $0.30 |
| EPS, diluted | -$107.01 | -$357.14 | $0.12 | $0.30 |
| Diluted shares | 334,762 | 25,844 | 5.2M | 5.2M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $1.78M | $191.0K | $142.0K | $193.5K |
| Current assets | $3.76M | $260.0K | $1.58M | $511.7K |
| Total assets | $3.77M | $3.07M | $10.88M | $194.74M |
| Current liabilities | $22.26M | $57.13M | $4.92M | $935.8K |
| Short-term debt | - | - | $200.0K | - |
| Total debt | - | $1.92M | - | - |
| Total liabilities | $30.43M | $57.13M | $5.09M | $1.83M |
| Shareholders' equity | -$26.66M | -$119.20M | -$110.00M | -$619.5K |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | -$16.25M | -$2.07M | -$2.06M | -$581.2K |
| Capital expenditures | $8.0K | - | - | - |
| Free cash flow | -$16.26M | - | - | - |
| Investing cash flow | -$2.01M | $2.97M | $185.60M | $33.4K |
| Financing cash flow | $19.84M | $2.12M | -$183.72M | - |
| Share repurchases | - | $3.25M | $184.85M | - |
| Stock-based compensation | $891.0K | $21.0K | - | - |
Key ratios
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $0 | $75.0K | - | - | - | - |
| Research and development | $823.0K | $1.15M | $1.25M | $722.0K | $393.0K | $434.0K | $259.0K | $411.0K | - | - | - | - |
| Selling, general and admin | $1.72M | $2.86M | $2.31M | $20.99M | $610.0K | $990.0K | $823.0K | $767.0K | - | - | - | - |
| Operating income | -$2.54M | -$4.01M | -$3.57M | -$21.71M | -$1.00M | -$1.42M | -$1.08M | -$1.10M | -$253.1K | -$470.8K | -$460.2K | -$290.1K |
| Interest expense | $21.0K | $18.0K | $25.0K | $169.0K | $1.19M | $1.14M | $1.29M | $1.07M | - | - | - | - |
| Pre-tax income | - | - | - | - | -$8.19M | -$1.10M | -$7.57M | $110.7K | -$374.5K | -$798.8K | $262.3K | -$341.8K |
| Income tax | - | - | - | - | $2.4K | $19.4K | $16.5K | $19.5K | $23.0K | $21.5K | $26.3K | $25.5K |
| Net income | -$8.76M | -$3.46M | -$8.57M | -$22.19M | -$2.35M | -$2.72M | -$2.25M | -$2.50M | -$2.41M | -$2.07M | $236.0K | -$367.3K |
| EPS, basic | -$151.80 | -$2.05 | - | -$0.70 | -$9100.78 | -$105.09 | - | -$1.29 | -$0.07 | -$0.14 | $0.02 | -$0.06 |
| EPS, diluted | -$151.80 | -$2.05 | - | -$0.70 | -$9100.78 | -$105.09 | - | -$1.29 | -$0.07 | -$0.14 | $0.02 | -$0.06 |
| Diluted shares | 57,676 | 1.7M | - | 31.7M | 258 | 25,844 | - | 1.9M | 5.2M | 5.2M | - | 5.2M |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $719.0K | $375.0K | $1.78M | $3.01M | $39.0K | $19.0K | $191.0K | $140.0K | $6.5K | $5.3K | $142.0K | $17.3K |
| Current assets | $841.0K | $662.0K | $3.76M | $4.20M | $687.9K | $63.2K | $260.0K | $681.9K | $113.5K | $66.1K | $1.58M | $153.0K |
| Total assets | $1.04M | $862.0K | $3.77M | $4.25M | $1.96M | $1.98M | $3.07M | $8.78M | $8.59M | $8.50M | $10.88M | $10.80M |
| Current liabilities | $28.17M | $29.02M | $22.26M | $23.54M | $16.18M | $13.25M | $57.13M | $5.17M | $4.16M | $3.96M | $4.92M | $3.00M |
| Short-term debt | - | - | - | - | - | - | - | - | - | - | $200.0K | - |
| Total debt | - | - | - | - | $1.92M | $1.92M | $1.92M | $1.91M | $1.83M | $1.50M | - | $713.0K |
| Total liabilities | $28.17M | $29.06M | $30.43M | $38.21M | $23.14M | $14.30M | $57.13M | $5.82M | $5.11M | $4.63M | $5.09M | $3.67M |
| Shareholders' equity | -$27.13M | -$28.20M | -$26.66M | -$33.96M | -$124.18M | -$121.92M | -$119.20M | -$116.96M | -$114.47M | -$112.06M | -$110.00M | -$3.48M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.63M | -$2.58M | -$5.13M | -$9.99M | -$589.0K | -$537.0K | -$238.0K | -$1.15M | -$394.9K | -$280.9K | -$345.2K | -$479.8K |
| Capital expenditures | $73.0K | $5.0K | - | - | - | - | - | - | - | - | - | - |
| Free cash flow | -$2.71M | -$2.58M | - | - | - | - | - | - | - | - | - | - |
| Investing cash flow | -$73.0K | $1.15M | -$1.01M | -$7.49M | -$1 | $6.49M | $457.9K | -$112.1K | $65.3K | $2.56M | -$76.4K | $147.9K |
| Financing cash flow | $3.05M | $28.0K | $4.91M | $13.96M | $609.0K | $365.0K | $289.0K | $3.77M | $330.8K | -$2.28M | $408.8K | $343.4K |
| Share repurchases | - | - | - | - | $0 | $6.51M | $595.4K | $0 | $0 | $2.65M | $0 | $0 |
| Stock-based compensation | $188.0K | $187.0K | $187.0K | $622.0K | $77.0K | $5.0K | $5.0K | - | - | - | - | - |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income growth, YoY | - | - | - | - | - | - | - | - | - | - | -51.1% | - |
| EPS growth, YoY | - | - | - | - | - | - | - | - | - | - | -60.0% | - |
| Operating margin | - | - | - | - | - | - | - | -1470.7% | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | -3329.3% | - | - | - | - |
| Current ratio | 0.03 | 0.02 | 0.17 | 0.18 | 0.04 | 0.00 | 0.00 | 0.13 | 0.03 | 0.02 | 0.32 | 0.05 |
Source: XBRL data Profusa Inc. files with the SEC, latest filing dated Aug 19, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
PFSA peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| PFSA | - | - | -$42.97M | - | $332,985 |
| SYK | $26.30B | +7.9% | $3.62B | 13.8% | $123.45B |
| MMM | $25.25B | +1.7% | $3.54B | 14.0% | $97.85B |
| BSX | $21.07B | +8.9% | $3.50B | 16.6% | $64.78B |
| BDX | $23.25B | +17.4% | $941.00M | 4.0% | $57.91B |
| MDLN | $30.68B | - | $683.00M | 2.2% | $53.81B |
| RMD | $5.73B | +9.0% | $1.59B | 27.8% | $32.93B |
| DXCM | $5.10B | +13.0% | $991.00M | 19.4% | $29.81B |
| WST | $3.40B | +12.6% | $638.90M | 18.8% | $28.74B |
PFSA FAQ
4 questionsIs PFSA profitable?
No. Profusa Inc. reported a net loss of $42.97M for the twelve months ended Jun 30, 2026.How much cash and debt does PFSA have?
Profusa Inc. reported $719.0K in cash and cash equivalents on its most recent balance sheet in SEC filings.When did PFSA last report financial results?
The latest statements here come from Profusa Inc.'s 10-Q filed on Aug 19, 2026, covering the period ended Jun 30, 2026.Where does this PFSA financial data come from?
Quantisnow builds these statements from the structured XBRL data Profusa Inc. files with the SEC. It is provided for information only and is not investment advice.